Company signals · Digital Health
Abridge
1 signal in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: Backdrop: a 107.2 (Hot) Talent Market Index (down 1.8 on the month) with Americas activity rising (+10.6pts).
Abridge: 1 signal in the last 90 days — in line with the Digital Health median of 1 across 61 tracked companies.
Signals at Abridge
MitchelLake in this thematic
More signals across Digital Health
Product Launch · Americas
CVS Health →CVS Health is expanding its pharmacy offering to include pet medications (antibiotics, allergy, flea/tick control, insulin, pain relievers) across ~9,000 locations nationwide, with digital integration into the CVS app and electronic prescription capabilities coming soon.
Product Launch · Americas
Innovaccer →Innovaccer formally launched Gravity for Infusion, a specialized AI infrastructure platform targeting the $100 billion U.S. infusion therapy market. The platform automates referral intake, benefits verification, prior authorization, and appointment scheduling for ambulatory infusion centers.
Product Launch · Americas
Wellhub →Wellhub launching first major US-market brand campaign with Terry Crews, produced by Surreal Hotel Arts. Campaign marks acceleration of US growth and expansion of platform beyond fitness to include mental health, mindfulness, nutrition, therapy, sleep services.
Product Launch · Americas
Ambience Healthcare →Ambience Healthcare introduced Nursing Summary and Ambient Flowsheet Documentation features to its clinical AI platform.
Product Launch · Americas
HELIX →HELIX launched HelixEngine.ai, a public-facing platform that provides direct access to the AI system powering the Learn Learn Learn podcast. First AI-driven episode of the series was scripted entirely by the system.
Product Launch · Americas
Cohere Health →Cohere Health is operating as the contracted tech vendor for Texas under CMS's WISeR Model, deploying AI-assisted prior authorization in Medicare. The program is live with 62% first-submission approval rates rising to 84% after physician review.
Intelligence powered by Autonodal ↗